It is noteworthy that even though our results show a remarkable decreasing tendency of CAP2 mRNA levels in the SFG of AD individuals, CAP2 protein levels were not affected, confirming the results obtained in previous studies [23]. This evidence concerns the gene CAP2 and Alzheimer disease.